Bowling N, Wyss V L, Gengo P J, Utterback B, Kauffman R F, Hayes J S
Department of Cardiovascular Pharmacology, Eli Lilly and Company, Indianapolis, IN 46285.
Eur J Pharmacol. 1990 Oct 9;187(2):155-64. doi: 10.1016/0014-2999(90)90002-n.
Effects of prolonged isoproterenol infusion upon the density of cardiac calcium channels, calcium-mediated contractile responses, and the ability of forskolin to enhance tension development and cyclic AMP accumulation were studied in ventricular muscle preparations from Sprague-Dawley rats. Isoproterenol infusion (400 micrograms/kg per h s.c., 4 days) significantly decreased calcium channel density (Bmax) in cardiac microsomal membranes as quantified by a 32% decrease in specific [3H]nitrendipine binding sites; binding affinity (KD) was unchanged. A 57% decrease of beta-adrenoceptors confirmed homologous down regulation. To examine functional effects of decreased [3H]nitrendipine binding sites, responses to calcium, BAY K8644 and nifedipine were determined in isolated right ventricular strips. Significant decreases in basal developed tension were observed in muscles from isoproterenol-infused rats. However, concentration-dependent increases in contractility in response to CaCl2 or BAY K8644 were comparable, and the negative inotropic effect of nifedipine was unchanged. Whereas isoproterenol infusion was associated with significantly decreased basal cardiac cyclic AMP concentrations, exposure of ventricular strips from either vehicle- or isoproterenol-infused rats to 10 microM forskolin resulted in comparable increases in cyclic AMP and in developed tension. Cumulative, submaximal concentrations of forskolin also produced similar increases in contractility with maximum responses in ventricular strips from vehicle-infused animals attained at 4.4 microM forskolin. Higher concentrations resulted in automaticity. By contrast, ventricle from isoproterenol-infused animals responded to 14.4 microM forskolin with maximal increases in force of contraction.
在来自Sprague-Dawley大鼠的心室肌制备物中,研究了长时间输注异丙肾上腺素对心脏钙通道密度、钙介导的收缩反应以及福斯可林增强张力发展和环磷酸腺苷(cAMP)积累能力的影响。输注异丙肾上腺素(400微克/千克每小时,皮下注射,4天)显著降低了心脏微粒体膜中的钙通道密度(Bmax),通过特异性[3H]尼群地平结合位点减少32%来量化;结合亲和力(KD)未改变。β-肾上腺素能受体减少57%证实了同源性下调。为了检查[3H]尼群地平结合位点减少的功能影响,在分离的右心室条带中测定了对钙、BAY K8644和硝苯地平的反应。在输注异丙肾上腺素的大鼠的肌肉中观察到基础张力发展显著降低。然而,对氯化钙或BAY K8644的收缩性浓度依赖性增加是相当的,并且硝苯地平的负性肌力作用未改变。虽然输注异丙肾上腺素与基础心脏cAMP浓度显著降低有关,但将来自用载体或异丙肾上腺素处理的大鼠的心室条带暴露于10微摩尔福斯可林会导致cAMP和张力发展有相当的增加。累积的、亚最大浓度的福斯可林也使收缩性产生类似的增加,在用载体处理的动物的心室条带中,在4.4微摩尔福斯可林时达到最大反应。更高的浓度导致自动节律性。相比之下,输注异丙肾上腺素的动物的心室对14.4微摩尔福斯可林的反应是收缩力最大增加。